State Street
MXCT icon

State Street’s MaxCyte MXCT Stock Holding History

State Street’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$636K Sell
516,750
-1,676,720
-76% -$1.67M ﹤0.01% 3533
2026
Q1 		$1.54M Sell
2,193,470
-164,914
-7% -$154K ﹤0.01% 3374
2025
Q4 		$3.66M Buy
2,358,384
+91,534
+4% +$146K ﹤0.01% 3124
2025
Q3 		$3.58M Buy
2,266,850
+83,947
+4% +$146K ﹤0.01% 3127
2025
Q2 		$4.76M Buy
2,182,903
+37,032
+2% +$89.7K ﹤0.01% 2966
2025
Q1 		$5.86M Buy
2,145,871
+1,649
+0.1% +$6.5K ﹤0.01% 2814
2024
Q4 		$8.92M Sell
2,144,222
-124,913
-6% -$472K ﹤0.01% 2693
2024
Q3 		$8.83M Buy
2,269,135
+111,066
+5% +$468K ﹤0.01% 2678
2024
Q2 		$8.46M Buy
2,158,069
+172,545
+9% +$742K ﹤0.01% 2657
2024
Q1 		$8.32M Buy
1,985,524
+41,527
+2% +$195K ﹤0.01% 2687
2023
Q4 		$9.14M Buy
1,943,997
+103,823
+6% +$404K ﹤0.01% 2647
2023
Q3 		$5.74M Buy
1,840,174
+27,800
+2% +$112K ﹤0.01% 2856
2023
Q2 		$8.32M Buy
1,812,374
+18,225
+1% +$83.8K ﹤0.01% 2738
2023
Q1 		$8.88M Buy
1,794,149
+2,582
+0.1% +$12.7K ﹤0.01% 2737
2022
Q4 		$9.78M Buy
1,791,567
+45,058
+3% +$276K ﹤0.01% 2702
2022
Q3 		$11.4M Buy
1,746,509
+189,814
+12% +$1.06M ﹤0.01% 2629
2022
Q2 		$7.36M Sell
1,556,695
-6,065
-0.4% -$29.9K ﹤0.01% 2890
2022
Q1 		$10.9M Buy
1,562,760
+252,201
+19% +$1.72M ﹤0.01% 2777
2021
Q4 		$13.4M Buy
1,310,559
+1,219,183
+1,334% +$13.1M ﹤0.01% 2742
2021
Q3 		$1.12M Buy
+91,376
New +$1.38M ﹤0.01% 3757

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

State Street's MXCT Position: Q2 2026 in Review

State Street reduced its MaxCyte (MXCT) stake by 76% in Q2 2026, selling an estimated $1.67M and leaving 516,750 shares worth $636K. The position accounts for ﹤0.01% of the portfolio, ranked #3533.

State Street first reported a position in MXCT in Q3 2021 and has held it in 20 quarters since. The position peaked at $13.4M in Q4 2021. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • State Street held 516,750 shares of MaxCyte worth $636K as of Q2 2026.
  • State Street sold 1,676,720 MaxCyte shares in Q2 2026, an estimated $1.67M.
  • MaxCyte made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3533 holding.
  • State Street first reported a position in MaxCyte in Q3 2021 and has held it in 20 quarters since.
  • State Street's MaxCyte position peaked at $13.4M in Q4 2021.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.